Cargando…
Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty: A meta-analysis of randomized controlled trials
BACKGROUND: Risedronate is widely used in the therapy of osteoporosis and other metabolic bone diseases. This meta-analysis was aimed to assess whether administration risedronate could increase the bone mineral density (BMD) in patients undergoing primary total hip arthroplasty (THA). METHODS: Elect...
Autores principales: | Su, Jing, Wei, Yi, Li, Xiao Ming, Diao, Yan-Ping, Liu, Huai-Gang, Zhang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320077/ https://www.ncbi.nlm.nih.gov/pubmed/30572438 http://dx.doi.org/10.1097/MD.0000000000013346 |
Ejemplares similares
-
Letter to the Editor: Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
por: Huang, Kai, et al.
Publicado: (2022) -
Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
por: Li, Qifeng, et al.
Publicado: (2018) -
Comment on “The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up”
por: Kai Huang, M. M., et al.
Publicado: (2022) -
Effect of risedronate on femoral periprosthetic bone loss following total hip replacement: A systematic review and meta-analysis
por: Ren, Liang, et al.
Publicado: (2018) -
CHANGES IN BONE MINERAL DENSITY AFTER TOTAL KNEE ARTHROPLASTY
por: DINCEL, YASAR MAHSUT, et al.
Publicado: (2020)